Semnur Pharmaceuticals, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
DE
Business Address
960 SAN ANTONIO ROAD, PALO ALTO, CA, 94303
Mailing Address
960 SAN ANTONIO ROAD, PALO ALTO, CA, 94303
Phone
(650) 516-4310
Fiscal Year End
1231
EIN
981659463
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 17, 2026 | View on SEC |
| 10-K Annual financial report | February 27, 2026 | View on SEC |
| S-1/A IPO registration amendment | December 19, 2025 | View on SEC |
| 8-K Current report of material events | December 3, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 12, 2025 | View on SEC |
| S-1 IPO registration statement | October 21, 2025 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | October 14, 2025 | View on SEC |
| 8-K Current report of material events | September 26, 2025 | View on SEC |
| 3 Initial insider ownership report | September 26, 2025 | View on SEC |
| 4 Insider stock transaction report | September 25, 2025 | View on SEC |
Annual Reports
10-K
February 27, 2026
- Clinical-stage biopharmaceutical company developing product candidates for pain management.
- Primary asset is SP-102, an investigational epidural steroid injection designed to treat sciatica.
Material Events
8-K
Leadership Change
March 17, 2026
High Impact
- New leadership (Dr. Henry Ji as CEO, Stephen Ma as COO) brings extensive experience and strong ties to controlling shareholder Scilex Holding Company.
- The transition signals a strategic shift towards tighter integration with Scilex, potentially leading to shared resources, streamlined decision-making, and faster development.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.